Follow the 코아스템켐온 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 코아스템켐온 has logged 38 insider filings. Market capitalisation: €81.7bn. The latest transaction was reported on 1 April 2026 (Sale). Among the most active insiders: 김경숙. All data is accessible without an account.
38
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
14 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,955 of 28,134 companies
6.0
score / 100
Value
9
Quality
3
FCF yld-19%
Earn yld-33%
EV/EBITDA·
ROE-66%
Gross mgn-20%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
코아스템켐온 is a company in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments and therapeutic solutions.